Lantheus Holdings (LNTH) Interest & Investment Income (2024 - 2026)
Lantheus Holdings' (LNTH) quarterly Interest & Investment Income came in at $5.0 million in Q1 2026, down 47.6% year-on-year from $9.5 million in Q1 2025, and up 61.7% on a QoQ basis from $3.1 million in Q4 2025.
Lantheus Holdings (LNTH) Interest & Investment Income (2024 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 3 years of Interest & Investment Income data on file, last reported at $5.0 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 47.6% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $18.9 million, a 50.02% decrease from a year earlier, with the FY2025 full-year figure at $23.4 million, down 36.5% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $5.0 million, up from $3.1 million in the prior quarter.
- Over the last five years, Interest & Investment Income for LNTH reached as high as $9.8 million in Q3 2024 and fell as low as $3.1 million in Q4 2025.
- Historically, Interest & Investment Income has averaged $7.1 million across 3 years, with a median of $8.1 million in 2024.
- On a YoY basis, Interest & Investment Income climbed as much as 19.17% in 2025 and fell as far as 67.87% in 2025.
- Year by year, Interest & Investment Income stood at $9.6 million in 2024, then plunged by 67.87% to $3.1 million in 2025, then jumped by 61.7% to $5.0 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $5.0 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 7.04 Bn | 6.54 Bn | 230.92 Mn | 4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.97 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.62 Mn |
| Jun 30, 2025 | 7.21 Mn |
| Mar 31, 2025 | 9.48 Mn |
| Dec 31, 2024 | 9.57 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Jun 30, 2024 | 8.92 Mn |